These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 7969059)
1. Mutations in the gyrB domain of eukaryotic topoisomerase II can lead to partially dominant resistance to etoposide and amsacrine. Nitiss JL; Vilalta PM; Wu H; McMahon J Mol Pharmacol; 1994 Oct; 46(4):773-7. PubMed ID: 7969059 [TBL] [Abstract][Full Text] [Related]
2. Functional expression of human topoisomerase II alpha in yeast: mutations at amino acids 450 or 803 of topoisomerase II alpha result in enzymes that can confer resistance to anti-topoisomerase II agents. Hsiung Y; Jannatipour M; Rose A; McMahon J; Duncan D; Nitiss JL Cancer Res; 1996 Jan; 56(1):91-9. PubMed ID: 8548781 [TBL] [Abstract][Full Text] [Related]
3. Yeast topoisomerase II mutants resistant to anti-topoisomerase agents: identification and characterization of new yeast topoisomerase II mutants selected for resistance to etoposide. Liu YX; Hsiung Y; Jannatipour M; Yeh Y; Nitiss JL Cancer Res; 1994 Jun; 54(11):2943-51. PubMed ID: 8187080 [TBL] [Abstract][Full Text] [Related]
4. Chinese hamster ovary cells resistant to the topoisomerase II catalytic inhibitor ICRF-159: a Tyr49Phe mutation confers high-level resistance to bisdioxopiperazines. Sehested M; Wessel I; Jensen LH; Holm B; Oliveri RS; Kenwrick S; Creighton AM; Nitiss JL; Jensen PB Cancer Res; 1998 Apr; 58(7):1460-8. PubMed ID: 9537249 [TBL] [Abstract][Full Text] [Related]
5. Analysis of yeast DNA topoisomerase II mutants resistant to the antitumor drug amsacrine. Wasserman RA; Wang JC Cancer Res; 1994 Apr; 54(7):1795-800. PubMed ID: 8137294 [TBL] [Abstract][Full Text] [Related]
6. Mutation E522K in human DNA topoisomerase IIbeta confers resistance to methyl N-(4'-(9-acridinylamino)-phenyl)carbamate hydrochloride and methyl N-(4'-(9-acridinylamino)-3-methoxy-phenyl) methane sulfonamide but hypersensitivity to etoposide. Leontiou C; Lakey JH; Austin CA Mol Pharmacol; 2004 Sep; 66(3):430-9. PubMed ID: 15322234 [TBL] [Abstract][Full Text] [Related]
7. A temperature sensitive topoisomerase II allele confers temperature dependent drug resistance on amsacrine and etoposide: a genetic system for determining the targets of topoisomerase II inhibitors. Nitiss JL; Liu YX; Hsiung Y Cancer Res; 1993 Jan; 53(1):89-93. PubMed ID: 8380128 [TBL] [Abstract][Full Text] [Related]
8. Random mutagenesis of the B'A' core domain of yeast DNA topoisomerase II and large-scale screens of mutants resistant to the anticancer drug etoposide. Jiang X Biochem Biophys Res Commun; 2005 Feb; 327(2):597-603. PubMed ID: 15629155 [TBL] [Abstract][Full Text] [Related]
9. DNA topoisomerase II mutations and resistance to anti-tumor drugs. Vassetzky YS; Alghisi GC; Gasser SM Bioessays; 1995 Sep; 17(9):767-74. PubMed ID: 8763829 [TBL] [Abstract][Full Text] [Related]
10. Increased sensitivity to quinolone antibacterials can be engineered in human topoisomerase IIalpha by selective mutagenesis. Hammonds TR; Foster SR; Maxwell A J Mol Biol; 2000 Jul; 300(3):481-91. PubMed ID: 10884345 [TBL] [Abstract][Full Text] [Related]
11. A novel point mutation in the 3' flanking region of the DNA-binding domain of topoisomerase II alpha associated with acquired resistance to topoisomerase II active agents. Hashimoto S; Danks MK; Chatterjee S; Beck WT; Berger NA Oncol Res; 1995; 7(1):21-9. PubMed ID: 7549041 [TBL] [Abstract][Full Text] [Related]
12. Mutations at arg486 and glu571 in human topoisomerase IIalpha confer resistance to amsacrine: relevance for antitumor drug resistance in human cells. Patel S; Keller BA; Fisher LM Mol Pharmacol; 2000 Apr; 57(4):784-91. PubMed ID: 10727526 [TBL] [Abstract][Full Text] [Related]
13. Mutations of human topoisomerase II alpha affecting multidrug resistance and sensitivity. Mao Y; Yu C; Hsieh TS; Nitiss JL; Liu AA; Wang H; Liu LF Biochemistry; 1999 Aug; 38(33):10793-800. PubMed ID: 10451375 [TBL] [Abstract][Full Text] [Related]
14. Amsacrine and etoposide hypersensitivity of yeast cells overexpressing DNA topoisomerase II. Nitiss JL; Liu YX; Harbury P; Jannatipour M; Wasserman R; Wang JC Cancer Res; 1992 Aug; 52(16):4467-72. PubMed ID: 1322791 [TBL] [Abstract][Full Text] [Related]
15. Single-strand conformational polymorphism analysis of the M(r) 170,000 isozyme of DNA topoisomerase II in human tumor cells. Danks MK; Warmoth MR; Friche E; Granzen B; Bugg BY; Harker WG; Zwelling LA; Futscher BW; Suttle DP; Beck WT Cancer Res; 1993 Mar; 53(6):1373-9. PubMed ID: 8383009 [TBL] [Abstract][Full Text] [Related]
16. DNA topoisomerase II is the molecular target of bisdioxopiperazine derivatives ICRF-159 and ICRF-193 in Saccharomyces cerevisiae. Ishida R; Hamatake M; Wasserman RA; Nitiss JL; Wang JC; Andoh T Cancer Res; 1995 Jun; 55(11):2299-303. PubMed ID: 7757979 [TBL] [Abstract][Full Text] [Related]
17. The top2-5 mutant of yeast topoisomerase II encodes an enzyme resistant to etoposide and amsacrine. Jannatipour M; Liu YX; Nitiss JL J Biol Chem; 1993 Sep; 268(25):18586-92. PubMed ID: 8395511 [TBL] [Abstract][Full Text] [Related]
18. [Incidence of mutation and deletion in topoisomerase II mRNA of etoposide and m-AMSA resistant cell lines]. Matsumoto Y; Morisaki K; Kunishio K; Nagao S; Takano H; Fojo T Gan To Kagaku Ryoho; 1998 Jul; 25(8):1145-9. PubMed ID: 9679576 [TBL] [Abstract][Full Text] [Related]
19. Transfection of a human topoisomerase II alpha gene into etoposide-resistant human breast tumor cells sensitizes the cells to etoposide. Asano T; An T; Zwelling LA; Takano H; Fojo AT; Kleinerman ES Oncol Res; 1996; 8(3):101-10. PubMed ID: 8823806 [TBL] [Abstract][Full Text] [Related]
20. Topoisomerase II-dependent and -independent mechanisms of etoposide resistance in Chinese hamster cell lines. Spiridonidis CA; Chatterjee S; Petzold SJ; Berger NA Cancer Res; 1989 Feb; 49(3):644-50. PubMed ID: 2535964 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]